Jivi and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Jivi and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Jivi-Moxifloxacin
- Jivi-Moxifloxacin (Systemic)
- Jivi-Moxifloxacin Hydrochloride
- Jivi-Moxifloxacin Injection
- Jivi-Moxifloxacin Intravenous
- Jivi-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Jivi Intravenous
- Moxetumomab pasudotox-tdfk Intravenous-Jolessa
- Moxetumomab pasudotox-tdfk Intravenous-Jolessa extended-cycle
- Moxetumomab pasudotox-tdfk Intravenous-Jolivette
- Moxetumomab pasudotox-tdfk Intravenous-Jornay PM
- Moxetumomab pasudotox-tdfk Intravenous-Juleber